Catalyst Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Catalyst Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $160,490 - $176,755	-2,210 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $856,663 - $1 Million	-14,478 Reduced 86.76%	2,210 $131,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $358,458 - $390,361	-5,790 Reduced 25.76%	16,688 $1.12 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $236,657 - $276,676	-4,317 Reduced 16.11%	22,478 $1.32 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $1.24 Million - $1.81 Million	26,795 New	26,795 $1.49 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.